Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab
Status:
Completed
Trial end date:
2017-05-15
Target enrollment:
Participant gender:
Summary
Performance assessment testing may be a useful tool to evaluate the impact of ranibizumab on
day-to-day visual function in patients with Diabetic Macular Edema (DME).